Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New iron supplement shows promise for anemia relief

NCT ID NCT07483645

Disease control Sponsor: Carnot Laboratories Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing a liposomal iron supplement with vitamin C and fiber (LISEFEX®) in 74 Mexican adults with mild to moderate iron deficiency anemia. Researchers are observing how well the supplement raises hemoglobin levels and how acceptable it is to patients. The supplement is prescribed by doctors as part of routine care, and the study simply collects data during follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Liposomal iron supplement with vitamin C and fiber (LISEFEX®)
What this could lead to
If effective, this supplement could offer a better-tolerated option to raise hemoglobin levels in people with mild to moderate iron deficiency anemia.
What could go wrong
This is a small observational study without a control group, so results may not prove the supplement works better than standard iron. Side effects like stomach upset are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

74 people

The number who actually took part.

Started

May 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Mexican population in the usual clínica

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of iron deficiency anemia. * Candidates over 18 years. * Candidates with Informed Consent signed. * Candidates who have been instructed by their treating physician to start treatment with LISEFEX * Candidates with the ability to swallow substances orally. Exclusion Criteria: * Pregnancy or breastfeeding. * Having received any treatment in the last 3 months for iron deficiency anemia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Iron deficiency anemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anemia iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Iron deficiency anemia

Contacts and locations

Locations

  • Winsett Rethman S.A. de C.V.

    Monterrey, Nuevo León, 64040, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.